The relationship between oxidative stress, nitric oxide, and coronary artery disease

European Journal of General Medicine

Volumn 4, Issue 2, 2007, Pages 62-66

  Soydinç, Serdar ^a   Çelik, Ahmet ^a   Demiryürek, Seniz ^b   Davutoǧlu, Vedat ^a   Tarakçioǧlu, Mehmet ^a   Aksoy, Mehmet ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Coronary artery disease; Malondialdehyde; Nitric oxide; Oxidative stress

Indexed keywords

CHOLESTEROL; MALONALDEHYDE; NITRIC OXIDE; TRIACYLGLYCEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; LIPID ANALYSIS; MALE; OXIDATIVE STRESS; STENOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 41549093261     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82487     Document Type: Article

References (16)

1. Holvoet P. Oxidative modification of low-density lipoproteins in atherothrombosis. Acta Cardiol 1998;53:253-60
2. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272:2963-6
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-6
4. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502
5. Draper H, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1980;186:421-31
6. Mendis S, Sobotka PA, Lejna FL, Euler DE. Breath pentane and plasma lipid peroxides in ischemic heart disease. Free Radic Biol Med 1995;19:679-84
7. Kostner K, Hornykewycz S, Yang P, et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 1997; 36:330-6
8. Pucheu S, Coundray C, Vanzetto G, Favier A, De Liris J. Assessment of radical activity during the acute phase of myocardial infarction following fibrinolysis: utility of assaying plasma malondialdehyde. Free Radic Biol Med 1995;19:873-81
9. Cavalca V, Cighetti G, Bamonti F, et al. Oxidative stress and homocysteine in coronary artery disease. Clin Chem 2001;47(5):887-92
10. Ribiere C, Jaubert AM, Gaudiot N, et al. White adipose tissue nitric oxide synthase: a potential source for NO production. Biochem Biophys Res Commun 1996;222:706-12
11. Elizalde M, Ryden M, van Harmelen V, et al. Expression of nitric oxide synthase in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res 2000;41:1244-51
12. Kelm M, Feelish M, Deussen A, Strauer BE, Schrader J. Release of endothelium-derived nitric oxide in relation to pressure and flow. Cardiovasc Res 1991; 25:831-6
13. Yoon Y, Song J, Hong SH, Kim JQ. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000;46(10):1626-30
14. Scribner AW, Loscalzo J, Napoli C. The effect of angiotensin-converting enzyme inhibition on endothelial function and oxidant stress. Eur J Pharmacol 2003;15;482(1-3):95-9
15. Napoli C, Ignarro LJ. Nitric oxide and atherosclerosis. Nitric Oxide 2001;5(2):88-97
16. Soysal D, Savas S, Susam I, et al. The association of plasma homocysteine, coronary risk factors and serum nitrite in patients with coronary artery disease, vascular syndrome X and healthy subjects. Anadolu Kardiyol 2003; 3(1):26-34